Why Clinical research is an integral component in medicines

clinical research

Clinical research is an integral component of developing new medicines and medical devices, with pharmaceutical, biotech and medical device companies often leading the charge in initiating and overseeing clinical trials.

CROs are hired to organize, direct, and execute trials safely and efficiently – this involves communicating with sponsors, ethics and compliance committees, regulatory personnel, vendors, physicians, and research coordinators throughout.

Study Management

Clinical research involves gathering data from trial participants and then analyzing it to evaluate whether a drug being evaluated is both safe and effective. Clinical Research Organization are responsible for overseeing this data collection process as well as ensuring trials adhere to regulatory requirements and ethical principles.

These CRO offer an array of services to the pharmaceutical industry. Some specialize in central laboratory services while others can manage all aspects of clinical trial management from data management, medical writing and biostatistics through to project management, human subject protection and pharmacovigilance.

When selecting a CRO, it is crucial that you consider their experience within your therapeutic area. A company familiar with your therapeutic area will have a better grasp on any opportunities or challenges which might arise during clinical trial process as well as being better equipped to identify optimal sites for study.

Consider how well a CRO works with your team and communicates with all parties involved in a clinical trial, especially how quickly they respond to issues that arise during its conduct and provide results on schedule. A good CRO will have fast turnaround times when responding to issues during trials as well as being able to deliver timely results.

Clinical trials can be costly and time consuming. But their information can help create new treatments to improve global health. Clinical research holds promise for an exciting future, as more companies turn to CROs as they work toward getting their treatments to market quickly and more cost effectively. By outsourcing day-to-day clinical research needs, companies will reduce costs while increasing productivity. CROs can assist drug manufacturers and patients alike by helping to detect costly mistakes before they occur, saving both time and money for everyone involved.

Data Management

Data management is an integral component of clinical trials, from preclinical phase through human trials and postmarketing surveillance. CROs are responsible for planning, coordinating, and overseeing every trial according to Good Clinical Practice guidelines or International Conference on Harmonization guidelines – so as to ensure safe conduct.

CROs can range from large international full service organizations to smaller niche specialty groups. CROs provide essential support in areas like regulatory affairs, site selection and activation, trial recruitment support, clinical monitoring or data management to reduce workloads for pharmaceutical companies conducting studies themselves; saving both money and resources needed for hiring staff and maintaining facilities year round.

Sponsors should prioritize selecting a CRO that can oversee all stages of clinical trial life cycle management and provide true partnership throughout. From concept creation through execution and monitoring of study to reporting back results, any CRO should be willing to discuss all aspects of a project with its sponsor at each step and suggest the most beneficial paths forward at every turn.

An effective CRO will be able to detect potential issues early and work with their sponsor to find solutions before these become major delays for trial. Therefore, selecting a CRO that offers complete services including regulatory affairs, pharmacovigilance, medical writing and biostatistics would be wise decision for drug developers.

PPD, as a global, full service CRO, offers comprehensive clinical development support services for therapeutic drugs and devices alike. Utilizing a strategic approach to project delivery, PPD assists sponsors to get their products to market more quickly while safeguarding quality through flexible yet innovative capabilities that ensure quality is never compromised. PPD achieves this through developing strong partnerships with clients while meeting individual client needs with cost effective yet high value solutions that exceed expectations.


Clinical research must be statistically informed for maximum effectiveness, which necessitates access to qualified biostatisticians who can provide input into its design, statistical considerations and monitoring activities, while providing assistance with data management and monitoring activities for each trial. Academic centers frequently advocate creating biostatistical collaboration networks as an efficient solution to meet clinical research’s demands.

This article presents the design, implementation and evaluation of a collaborative biostatistics network in a university health system (UHHS). The project team created a network that provides clinically integrated collaborative biostatisticians with training opportunities. Results show that this type of network may be feasible and offer effective support for clinical research at UHHS.

CROs provide clinical trial sponsors with many functions normally handled internally by sponsors, such as site selection, patient enrollment and data management, disease coding, cleaning/analysis/validation programming/submission to regulatory bodies/safety/efficacy summaries preparation – saving sponsor companies both time, money and effort during drug development processes. This outsourcing strategy may save sponsor companies both money and effort while expediting drug development process.

The project team gathered information about the leadership of collaborative biostatistics units. This data included their sociodemographic characteristics, highest degree earned and years of professional experience; current job titles; primary academic appointment affiliations; percent distribution of working hours between administrative duties, mentoring or teaching duties, participating in funded collaborative research; non-funded university service work or any other activity types; as well as any activity types they might undertake.

An initial step was to identify all faculty and staff biostatisticians at the university, with particular attention paid to those conducting clinical and translational research. We used multiple institutional sources such as biostatisticians’ professional profiles and HR records as sources for this data collection process, in addition to surveying collaborative biostatistics leaders and their colleagues.

The network was designed to include both Principal Investigators (PIs) and staff who were clinically integrated but excluded actively enrolled students due to their limited statistical expertise and short tenure at university. With this evaluation method, the project team tracked growth in each individual’s competency concerning skills listed in Table 1. Regular evaluations were held to track progress and provide feedback.


SpinoS’s Clinical Research Service model provides smaller practices the opportunity to take part in clinical trials previously only available at larger institutions. Our network of ready-to-go investigational sites streamlines patient enrollment, centralizes data collection, and offers cost-effective clinical trial management solutions.

Intraoperative neurophysiological monitoring (MIOM) has become an integral component of surgery on spinal tumors. MIOM helps identify systemic effects due to medications or anesthetics from direct surgical-related changes; hence multimodal intraoperative monitoring with somatosensory spinal and cerebral evoked potential as well as electromyography (EMG) monitoring is used.

MIOM requires extensive knowledge of surgical procedures, anticipated neurological complications, and risk assessment for individual patients to effectively apply it. A multimodal approach combined with expert neurophysiologic monitoring is critical in order to achieve successful clinical results and minimize any false negative cases. Furthermore, monitoring both ascending and descending pathways simultaneously is also key as this allows doctors to distinguish systemic changes from surgery-related changes more reliably and valid results can reduce false negative cases significantly.